Cargando…
Risk for uveitis relapse after COVID-19 vaccination
OBJECTIVES: Several studies suggested that coronavirus disease 2019 (COVID-19) vaccination may lead to uveitis, a vision-threatening condition often associated with a variety of autoimmune or autoinflammatory diseases. This study aims to explore factors that influence the risk of uveitis relapse aft...
Autores principales: | Zhong, Zhenyu, Wu, Qiuying, Lai, Yuxian, Dai, Lingyu, Gao, Yu, Liao, Weiting, Feng, Xiaojie, Yang, Peizeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531657/ https://www.ncbi.nlm.nih.gov/pubmed/36209692 http://dx.doi.org/10.1016/j.jaut.2022.102925 |
Ejemplares similares
-
Early vs Deferred Non–Messenger RNA COVID-19 Vaccination Among Chinese Patients With a History of Inactive Uveitis: A Randomized Clinical Trial
por: Zhong, Zhenyu, et al.
Publicado: (2023) -
Comparative Efficacy and Safety of Advanced Intravitreal Therapeutic Agents for Noninfectious Uveitis: A Systematic Review and Network Meta-Analysis
por: Liao, Weiting, et al.
Publicado: (2022) -
Association between uveitis onset and economic development in mainland China
por: Tan, Handan, et al.
Publicado: (2023) -
HMG-Coenzyme A Reductase as a Drug Target for the Prevention of Ankylosing Spondylitis
por: Zhong, Zhenyu, et al.
Publicado: (2021) -
A randomized non-inferiority trial of therapeutic strategy with immunosuppressants versus biologics for Vogt-Koyanagi-Harada disease
por: Zhong, Zhenyu, et al.
Publicado: (2023)